Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$318.15+0.61 (+0.19%)
Close on Nov 18, 2026Market cap $121.12BP/E 33.9Yield –
Stryker operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Stryker's operating income for the twelve months ending Sep 30, 2026 was $5.43B, up 48.2% year over year. For fiscal 2025 it was $4.89B, up 32.5% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $4.89B in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89B | +32.5% |
| FY2024 | Dec 31, 2024 | $3.69B | -5.1% |
| FY2023 | Dec 31, 2023 | $3.89B | +36.9% |
| FY2022 | Dec 31, 2022 | $2.84B | +9.9% |
| FY2021 | Dec 31, 2021 | $2.58B | +16.2% |
| FY2020 | Dec 31, 2020 | $2.22B | -18.1% |
| FY2019 | Dec 31, 2019 | $2.71B | +6.9% |
| FY2018 | Dec 31, 2018 | $2.54B | +10.4% |
| FY2017 | Dec 31, 2017 | $2.30B | +5.6% |
| FY2016 | Dec 31, 2016 | $2.18B | +16.9% |
| FY2015 | Dec 31, 2015 | $1.86B | +49.4% |
| FY2014 | Dec 31, 2014 | $1.25B | -0.8% |
| FY2013 | Dec 31, 2013 | $1.26B | -27.9% |
| FY2012 | Dec 31, 2012 | $1.74B | +3.3% |
| FY2011 | Dec 31, 2011 | $1.69B | -3.7% |
| FY2010 | Dec 31, 2010 | $1.75B | +9.8% |
| FY2009 | Dec 31, 2009 | $1.59B | +4.9% |
| FY2008 | Dec 31, 2008 | $1.52B | +16.2% |
| FY2007 | Dec 31, 2007 | $1.31B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.03B | -8.9% |
| Q2 FY2026 | Jun 30, 2026 | $1.66B | +49.1% |
| Q1 FY2026 | Mar 31, 2026 | $936.00M | +11.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.80B | +210.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.14B | +4.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.11B | +5.9% |
| Q1 FY2025 | Mar 31, 2025 | $837.00M | -13.9% |
| Q4 FY2024 | Dec 31, 2024 | $581.00M | -53.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.09B | +16.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.05B | +8.9% |
| Q1 FY2024 | Mar 31, 2024 | $972.00M | +32.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.26B | +54.4% |
| Q3 FY2023 | Sep 30, 2023 | $931.00M | +15.2% |
| Q2 FY2023 | Jun 30, 2023 | $965.00M | +25.0% |
| Q1 FY2023 | Mar 31, 2023 | $735.00M | +64.4% |
| Q4 FY2022 | Dec 31, 2022 | $814.00M | -0.6% |
| Q3 FY2022 | Sep 30, 2022 | $808.00M | +40.8% |
| Q2 FY2022 | Jun 30, 2022 | $772.00M | +5.5% |
| Q1 FY2022 | Mar 31, 2022 | $447.00M | -2.6% |
| Q4 FY2021 | Dec 31, 2021 | $819.00M | +9.3% |
| Q3 FY2021 | Sep 30, 2021 | $574.00M | -33.2% |
| Q2 FY2021 | Jun 30, 2021 | $732.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $459.00M | -27.7% |
| Q4 FY2020 | Dec 31, 2020 | $749.00M | -20.7% |
| Q3 FY2020 | Sep 30, 2020 | $859.00M | +36.8% |
| Q2 FY2020 | Jun 30, 2020 | -$20.00M | -103.3% |
| Q1 FY2020 | Mar 31, 2020 | $635.00M | +20.3% |
| Q4 FY2019 | Dec 31, 2019 | $944.00M | +35.2% |
| Q3 FY2019 | Sep 30, 2019 | $628.00M | +9.0% |
| Q2 FY2019 | Jun 30, 2019 | $613.00M | -8.8% |
| Q1 FY2019 | Mar 31, 2019 | $528.00M | -10.7% |
| Q4 FY2018 | Dec 31, 2018 | $698.00M | -2.2% |
| Q3 FY2018 | Sep 30, 2018 | $576.00M | +9.7% |
| Q2 FY2018 | Jun 30, 2018 | $672.00M | +33.9% |
| Q1 FY2018 | Mar 31, 2018 | $591.00M | +6.3% |
| Q4 FY2017 | Dec 31, 2017 | $714.00M | +6.6% |
| Q3 FY2017 | Sep 30, 2017 | $525.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $502.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $556.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $670.00M | – |
See a number that looks wrong?